Breaking News on Contract Research, Manufacturing & Clinical Trials

Read more breaking news


News in brief

Recipharm adds capacity through ViroPharma contract

Last updated on 15-Mar-2012 at 09:37 GMT2012-03-15T09:37:25Z

Recipharm adds capacity through ViroPharma contract

Swedish CDMO Recipharm will gain manufacturing capacity through its new production contract with ViroPharma.

Under the deal – which will see Recipharm make commercial supplies of the adrenal insufficiency drug Plenadren – ViroPharma will invest in new tablet manufacturing and active pharmaceutical ingredient (API) coating technology to be installed at the CDMO’s plant in Arsta, Stockholm

The agreement follows Recipharm’s completion of a scale-up contract with original Plenadren developer Sweden-based DuoCort, which was acquired by ViroPharma in November for an upfront payment of $33m (€25m).

Helene Fehrm, General Manager at Recipharm Stockholm told that: “we will be able to use the technology for other customers” although the US drugmaker “retains its status as a customer with the highest priority.”

Key Industry Events


Access all events listing

Our events, Shows & Conferences...